For the first time, a stem cell-based device reduced insulin required for some with Type 1 diabetes. It contains millions of lab-grown pancreatic islet cells implanted just beneath the skin. 6 months later, 3 participants showed insulin production and maintained levels through the year-long study.

For the first time, a stem cell-based device reduced insulin required for some with Type 1 diabetes. It contains millions of lab-grown pancreatic islet cells implanted just beneath the skin. 6 months later, 3 participants showed insulin production and maintained levels through the year-long study.